CONMED Corporation (CNMD) announced on Friday its preliminary financial performance for the third quarter. The company anticipates revenue between $315 million and $318 million, with adjusted net earnings per share expected to grow beyond the previously forecasted range of 9% to 11%.
Analysts, on average, project earnings of $0.99 per share on revenues of $318.67 million for the quarter, according to data from Thomson Reuters. These analyst projections typically do not account for any special items.
CONMED has scheduled the release of its complete financial results for the third quarter of 2024 for after market close on Wednesday, October 30, 2024.
